BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 118 filers reported holding BIOSCRIP INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $336,000 | -23.1% | 168,200 | -59.9% | 0.07% | -25.0% |
Q4 2016 | $437,000 | -93.2% | 419,831 | -81.2% | 0.09% | -93.3% |
Q3 2016 | $6,467,000 | +13.3% | 2,237,608 | 0.0% | 1.38% | +0.4% |
Q2 2016 | $5,706,000 | +115.5% | 2,237,608 | +80.8% | 1.37% | +118.1% |
Q1 2016 | $2,648,000 | +94.6% | 1,237,608 | +59.1% | 0.63% | +101.9% |
Q4 2015 | $1,361,000 | -68.2% | 777,920 | -66.1% | 0.31% | -69.8% |
Q3 2015 | $4,285,000 | -23.2% | 2,291,529 | +49.1% | 1.03% | -6.9% |
Q2 2015 | $5,577,000 | -43.0% | 1,536,469 | -30.4% | 1.11% | -43.5% |
Q1 2015 | $9,785,000 | -37.1% | 2,208,710 | -0.8% | 1.96% | -22.7% |
Q4 2014 | $15,564,000 | +7.7% | 2,226,561 | +6.5% | 2.54% | -10.8% |
Q3 2014 | $14,447,000 | -17.1% | 2,090,789 | 0.0% | 2.85% | -7.1% |
Q2 2014 | $17,437,000 | +2.4% | 2,090,789 | -14.3% | 3.07% | -4.5% |
Q1 2014 | $17,023,000 | -5.7% | 2,438,846 | 0.0% | 3.21% | -6.3% |
Q4 2013 | $18,047,000 | +91.8% | 2,438,846 | +127.6% | 3.43% | +71.8% |
Q3 2013 | $9,408,000 | +15.5% | 1,071,560 | +117.1% | 2.00% | +4.4% |
Q2 2013 | $8,143,000 | – | 493,503 | – | 1.91% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |